The past few years in the biotech industry have been filled with challenges and promise.
From the rapid and successful deployment of the COVID-19 vaccine and the explosion of the cell and gene therapy sector to a hiring boom, remarkable advances in tissue engineering and strong biomanufacturing growth, the BioHealth Capital Region (BHCR) has played a pivotal role in it all.
To say a lot has changed is the understatement of the century. The question remains, however: Where is the BHCR headed?





AstraZenecaย CEO Pascal Soriot raised questions Tuesday about the companyโs future in vaccines while hinting at potential M&A activity on the near horizon.














